Hanover Insurance Group Inc (NYSE: THG) |
|
|
|
Hanover Insurance Group Inc Income Statement Quarterly
THG
Select the Financial Report: |
Period: |
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2024) Q3 2024 |
(Jun 30 2024) Q2 2024 |
(Mar 31 2024) Q1 2024 |
(Dec 31 2023) Q4 2023 |
(Sep 30 2023) Q3 2023 |
Premiums Earned, Net |
1,479.20 |
1,473.20 |
1,448.60 |
1,440.30 |
1,431.10 |
Other Revenue |
11.80 |
29.30 |
-5.20 |
-0.80 |
6.10 |
Fees Commissions And Other Income |
6.70 |
7.60 |
7.30 |
7.60 |
7.40 |
Equity Securities Fv Ni Gain Loss |
11.70 |
1.10 |
6.50 |
7.80 |
-5.20 |
Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings |
- |
- |
- |
- |
- |
Gain Loss On Investments From Continuing Operations |
-12.40 |
-34.50 |
5.50 |
-0.70 |
-6.10 |
Investments Gain (Loss), Net |
68.30 |
60.00 |
88.40 |
74.60 |
83.30 |
Total Revenue |
1,565.30 |
1,536.70 |
1,551.10 |
1,528.80 |
1,516.60 |
Deferred Policy Acquisition Cost, Amortization Expense |
307.80 |
303.50 |
299.00 |
1,213.70 |
296.60 |
Policyholder Benefits and Claims Incurred, Net |
954.00 |
1,007.60 |
935.20 |
- |
1,061.50 |
Gross
profit |
303.50 |
225.60 |
316.90 |
315.10 |
158.50 |
Selling, Administration, Marketing |
- |
- |
- |
- |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
- |
- |
- |
- |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Interest expense |
- |
- |
- |
- |
- |
Interest Expense, Debt |
8.50 |
8.60 |
8.50 |
8.50 |
8.50 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
8.50 |
8.60 |
8.50 |
8.50 |
8.50 |
Other loss/ -income |
97.00 |
105.70 |
74.70 |
164.90 |
67.60 |
Total costs & expenses |
1,435.60 |
1,485.40 |
1,405.80 |
1,378.60 |
1,517.50 |
Income /-loss before income taxes |
129.70 |
51.30 |
145.30 |
150.20 |
-0.90 |
Income taxes expenses/-benefit |
18.50 |
4.80 |
30.90 |
74.30 |
-17.10 |
Income after income taxes |
102.10 |
40.40 |
115.50 |
107.30 |
8.20 |
Net income/-loss
of other equity |
-9.10 |
-6.10 |
1.10 |
30.80 |
-7.60 |
Income/-loss
from cont. Ops. |
102.10 |
40.40 |
115.50 |
106.70 |
8.60 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
0.10 |
- |
1.20 |
- |
Discontinued Operation Gain Loss From Operations Of Discontinued Accident And Health Business Net Of Tax |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
102.10 |
40.50 |
115.50 |
107.90 |
8.60 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
102.10 |
40.50 |
115.50 |
107.90 |
8.60 |
EBIT |
138.20 |
59.90 |
153.80 |
158.70 |
7.60 |
EBITD |
138.70 |
60.70 |
154.60 |
159.50 |
9.10 |
EBITDA |
138.70 |
60.70 |
154.60 |
159.50 |
9.10 |
Per
Share (GAAP Quarterly, in $) |
(Sep 30 2024) Q3 2024 |
(Jun 30 2024) Q2 2024 |
(Mar 31 2024) Q1 2024 |
(Dec 31 2023) Q4 2023 |
(Sep 30 2023) Q3 2023 |
Basic EPS (excl. extra
items) |
2.84 |
1.12 |
3.22 |
3.01 |
0.23 |
Extraordinary items |
0.00 |
0.01 |
0.00 |
-0.01 |
0.00 |
Basic Net EPS |
2.84 |
1.13 |
3.22 |
3.02 |
0.24 |
Basic shares outstanding (Mill.
of Units) |
36.00 |
36.00 |
35.80 |
35.70 |
35.80 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
2.80 |
1.12 |
3.18 |
2.92 |
0.24 |
Diluted average shares (Mill.
of Units) |
36.50 |
36.30 |
36.30 |
36.02 |
36.10 |
Dividend per share |
0.838 |
0.843 |
0.84 |
0.841 |
0.803 |
|